Literature DB >> 8092840

Interaction of oxyimino beta-lactams with a class C beta-lactamase and a mutant with a spectrum extended to beta-lactams.

M Nukaga1, K Tsukamoto, H Yamaguchi, T Sawai.   

Abstract

The class C beta-lactamase of Citrobacter freundii GN346 is a typical cephalosporinase comprising 361 amino acids, and substitution of the glutamic acid at position 219 in the enzyme by lysine was previously shown to broaden its substrate spectrum to oxyimino beta-lactams (K. Tsukamoto, R. Ohno, and T. Sawai, J. Bacteriol. 172:4348-4351, 1990). To clarify this spectrum extension from the kinetic point of view, the interactions of cefuroxime, ceftazidime, and aztreonam with the wild-type and mutant enzymes were analyzed. In addition to aztreonam, known as a progressive inhibitor of class C beta-lactamases, cefuroxime and ceftazidime were found to act as progressive inhibitors of the wild-type enzyme. On the other hand, only aztreonam showed weak progressive inhibition of the mutant enzyme. On the basis of kinetic parameters, a minimum scheme for interaction of the oxyimino beta-lactams with the wild-type enzyme was proposed, and the rate-limiting step of the hydrolysis of unfavorable substrates was indicated to be conversion of the stable acyl-enzyme intermediate to the unstable intermediate. In aztreonam hydrolysis by the mutant enzyme, the reaction rate at the rate-limiting step was 2,000 times that of the wild-type enzyme. These results indicate that the mutation at position 219 disturbs the stabilization of the stable intermediate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092840      PMCID: PMC188213          DOI: 10.1128/AAC.38.6.1374

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  The kinetics of substrate-induced inactivation.

Authors:  S G Waley
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

2.  Inhibition of beta-lactamase of Bacillus licheniformis 749/C by compound PS-5, a new beta-lactam antibiotic.

Authors:  Y Fukagawa; T Takei; T Ishikura
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

3.  Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase.

Authors:  K Tsukamoto; R Ohno; T Sawai
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

4.  A simple method for calculating Km and V from a single enzyme reaction progress curve.

Authors:  S L Yun; C H Suelter
Journal:  Biochim Biophys Acta       Date:  1977-01-11

5.  Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

6.  Characterization of eight beta-lactamases of Gram-negative bacteria.

Authors:  T Sawai; M Kanno; K Tsukamoto
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

7.  Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria.

Authors:  K Bush; J S Freudenberger; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

8.  Mechanism of beta-lactamase inhibition: differences between sulbactam and other inhibitors.

Authors:  T Sawai; A Yamaguchi
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Jul-Aug       Impact factor: 2.803

9.  Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  J Fisher; R L Charnas; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

10.  Role of lysine-67 in the active site of class C beta-lactamase from Citrobacter freundii GN346.

Authors:  K Tsukamoto; K Tachibana; N Yamazaki; Y Ishii; K Ujiie; N Nishida; T Sawai
Journal:  Eur J Biochem       Date:  1990-02-22
View more
  1 in total

1.  Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.

Authors:  Sandrine Dahyot; Hedi Mammeri
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.